請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66204完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 周祖述 | |
| dc.contributor.author | Yu-Yu Lin | en |
| dc.contributor.author | 林俞妤 | zh_TW |
| dc.date.accessioned | 2021-06-17T00:25:33Z | - |
| dc.date.available | 2013-09-18 | |
| dc.date.copyright | 2012-09-18 | |
| dc.date.issued | 2012 | |
| dc.date.submitted | 2012-03-27 | |
| dc.identifier.citation | 1. Clevers, H. 2006. Wnt/beta-catenin signaling in development and disease. Cell
127:469-480. 2. Wallingford, J.B., and Habas, R. 2005. The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development 132:4421-4436. 3. Kawano, Y., and Kypta, R. 2003. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627-2634. 4. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K.W. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790. 5. Korinek, V., Barker, N., Morin, P.J., van Wichen, D., de Weger, R., Kinzler, K.W., Vogelstein, B., and Clevers, H. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784-1787. 6. de La Coste, A., Romagnolo, B., Billuart, P., Renard, C.A., Buendia, M.A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. 1998. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 95:8847-8851. 7. Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., and Nakamura, Y. 1998. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58:2524-2527. 8. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., and Polakis, P. 1997. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275:1790-1792. 9. Schneikert, J., and Behrens, J. 2007. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56:417-425. 10. Nelson, W.J., and Nusse, R. 2004. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487. 11. Giles, R.H., van Es, J.H., and Clevers, H. 2003. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653:1-24. 12. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.H., Tan, Y., Zhang, Z., Lin, X., and He, X. 2002. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108:837-847. 13. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., 69 Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. 1996. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86:391-399. 14. Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. 1996. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638-642. 15. Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H., Moerer, P., van de Wetering, M., Destree, O., and Clevers, H. 1998. The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395:608-612. 16. Brantjes, H., Roose, J., van De Wetering, M., and Clevers, H. 2001. All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res 29:1410-1419. 17. Daniels, D.L., and Weis, W.I. 2005. β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nature Structural & Molecular Biology 12:364-371. 18. Fagotto, F., Gluck, U., and Gumbiner, B.M. 1998. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Current Biology 8:181-190. 19. Yokoya, F., Imamoto, N., Tachibana, T., and Yoneda, Y. 1999. beta-catenin can be transported into the nucleus in a Ran-unassisted manner. Molecular Biology of the Cell 10:1119-1131. 20. Koike, M., Kose, S., Furuta, M., Taniguchi, N., Yokoya, F., Yoneda, Y., and Imamoto, N. 2004. beta-Catenin shows an overlapping sequence requirement but distinct molecular interactions for its bidirectional passage through nuclear pores. Journal of Biological Chemistry 279:34038-34047. 21. Krieghoff, E., Behrens, J., and Mayr, B. 2006. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. Journal of Cell Science 119:1453-1463. 22. Cong, F., and Varmus, H. 2004. Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proceedings of the National Academy of Sciences of the United States of America 101:2882-2887. 23. Henderson, B.R. 2000. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nature Cell Biology 2:653-660. 24. Neufeld, K.L., Zhang, F., Cullen, B.R., and White, R.L. 2000. APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and 70 nuclear export. EMBO Reports 1:519-523. 25. Tetsu, O., and McCormick, F. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426. 26. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B., and Kinzler, K.W. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512. 27. Huang, W.S., Wang, J.P., Wang, T., Fang, J.Y., Lan, P., and Ma, J.P. 2007. ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells. World Journal of Gastroenterology 13:6581-6587. 28. Verma, U.N., Surabhi, R.M., Schmaltieg, A., Becerra, C., and Gaynor, R.B. 2003. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 9:1291-1300. 29. Sansom, O.J., Meniel, V.S., Muncan, V., Phesse, T.J., Wilkins, J.A., Reed, K.R., Vass, J.K., Athineos, D., Clevers, H., and Clarke, A.R. 2007. Myc deletion rescues Apc deficiency in the small intestine. Nature 446:676-679. 30. Hurlstone, A., and Clevers, H. 2002. T-cell factors: turn-ons and turn-offs. EMBO J 21:2303-2311. 31. van Noort, M., and Clevers, H. 2002. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 244:1-8. 32. Arce, L., Yokoyama, N.N., and Waterman, M.L. 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25:7492-7504. 33. Van de Wetering, M., Castrop, J., Korinek, V., and Clevers, H. 1996. Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties. Mol Cell Biol 16:745-752. 34. Hovanes, K., Li, T.W., Munguia, J.E., Truong, T., Milovanovic, T., Lawrence Marsh, J., Holcombe, R.F., and Waterman, M.L. 2001. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nature Genetics 28:53-57. 35. Waterman, M.L. 2004. Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev 23:41-52. 36. Barolo, S. 2006. Transgenic Wnt/TCF pathway reporters: all you need is Lef? Oncogene 25:7505-7511. 37. Vlad, A., Rohrs, S., Klein-Hitpass, L., and Muller, O. 2008. The first five years of the Wnt targetome. Cell Signal 20:795-802. 38. Brabletz, T., Jung, A., Dag, S., Hlubek, F., and Kirchner, T. 1999. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155:1033-1038. 71 39. Hatzis, P., van der Flier, L.G., van Driel, M.A., Guryev, V., Nielsen, F., Denissov, S., Nijman, I.J., Koster, J., Santo, E.E., Welboren, W., et al. 2008. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Molecular & Cellular Biology 28:2732-2744. 40. Bottomly, D., Kyler, S.L., McWeeney, S.K., and Yochum, G.S. 2010. Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 38:5735-5745. 41. van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.P., et al. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241-250. 42. Tang, W., Dodge, M., Gundapaneni, D., Michnoff, C., Roth, M., and Lum, L. 2008. A genome-wide RNAi screen for Wnt/β-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proceedings of the National Academy of Sciences 105:9697-9702. 43. Angus-Hill, M.L., Elbert, K.M., Hidalgo, J., and Capecchi, M.R. 2011. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 108:4914-4919. 44. van de Wetering, M., Oosterwegel, M., Dooijes, D., and Clevers, H. 1991. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO Journal 10:123-132. 45. Willinger, T., Freeman, T., Herbert, M., Hasegawa, H., McMichael, A.J., and Callan, M.F. 2006. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. J Immunol 176:1439-1446. 46. Voltz, J.W., Weinman, E.J., and Shenolikar, S. 2001. Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene 20:6309-6314. 47. Shenolikar, S., and Weinman, E.J. 2001. NHERF: targeting and trafficking membrane proteins. Am J Physiol Renal Physiol 280:F389-395. 48. Ediger, T.R., Kraus, W.L., Weinman, E.J., and Katzenellenbogen, B.S. 1999. Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 140:2976-2982. 49. Morales, F.C., Takahashi, Y., Kreimann, E.L., and Georgescu, M.M. 2004. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM 72 proteins at the apical membrane of polarized epithelia. Proc Natl Acad Sci U S A 101:17705-17710. 50. Thelin, W.R. 2005. Beyond the brush border: NHERF4 blazes new NHERF turf. The Journal of Physiology 567:13-19. 51. Donowitz, M., Cha, B., Zachos, N.C., Brett, C.L., Sharma, A., Tse, C.M., and Li, X. 2005. NHERF family and NHE3 regulation. J Physiol 567:3-11. 52. Hughes, S.C., Formstecher, E., and Fehon, R.G. 2010. Sip1, the Drosophila orthologue of EBP50/NHERF1, functions with the sterile 20 family kinase Slik to regulate Moesin activity. Journal of Cell Science 123:1099-1107. 53. Shenolikar, S., Voltz, J.W., Cunningham, R., and Weinman, E.J. 2004. Regulation of ion transport by the NHERF family of PDZ proteins. Physiology 19:362-369. 54. Ediger, T.R., Park, S.E., and Katzenellenbogen, B.S. 2002. Estrogen receptor inducibility of the human Na+/H+ exchanger regulatory factor/ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements. Molecular Endocrinology 16:1828-1839. 55. Cardone, R.A., Bellizzi, A., Busco, G., Weinman, E.J., Dell'Aquila, M.E., Casavola, V., Azzariti, A., Mangia, A., Paradiso, A., and Reshkin, S.J. 2007. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Molecular Biology of the Cell 18:1768-1780. 56. Dai, J.L., Wang, L., Sahin, A.A., Broemeling, L.D., Schutte, M., and Pan, Y. 2004. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 23:8681-8687. 57. Kreimann, E.L., Morales, F.C., de Orbeta-Cruz, J., Takahashi, Y., Adams, H., Liu, T.J., McCrea, P.D., and Georgescu, M.M. 2007. Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 26:5290-5299. 58. Takahashi, Y., Morales, F.C., Kreimann, E.L., and Georgescu, M.M. 2006. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 25:910-920. 59. Fouassier, L., Rosenberg, P., Mergey, M., Saubamea, B., Claperon, A., Kinnman, N., Chignard, N., Jacobsson-Ekman, G., Strandvik, B., Rey, C., et al. 2009. Ezrin-Radixin-Moesin-Binding Phosphoprotein (EBP50), an Estrogen-Inducible Scaffold Protein, Contributes to Biliary Epithelial Cell Proliferation. American Journal Of Pathology 174:869-880. 73 60. Song, G.J., Barrick, S., Leslie, K.L., Bauer, P.M., Alonso, V., Friedman, P.A., Fiaschi-Taesch, N.M., and Bisello, A. 2012. The Scaffolding Protein EBP50 Promotes Vascular Smooth Muscle Cell Proliferation and Neointima Formation by Regulating Skp2 and p21cip1. Arterioscler Thromb Vasc Biol 32:33-41. 61. Kislin, K.L., McDonough, W.S., Eschbacher, J.M., Armstrong, B.A., and Berens, M.E. 2009. NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia (New York) 11:377-387. 62. Georgescu, M.M., Morales, F.C., Molina, J.R., and Hayashi, Y. 2008. Roles of NHERF1/EBP50 in cancer. Current Molecular Medicine 8:459-468. 63. Shibata, T., Chuma, M., Kokubu, A., Sakamoto, M., and Hirohashi, S. 2003. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 38:178-186. 64. Tang, L.Y., Deng, N., Wang, L.S., Dai, J., Wang, Z.L., Jiang, X.S., Li, S.J., Li, L., Sheng, Q.H., Wu, D.Q., et al. 2007. Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction. Mol Cell Proteomics 6:1952-1967. 65. Wheeler, D.S., Barrick, S.R., Grubisha, M.J., Brufsky, A.M., Friedman, P.A., and Romero, G. 2011. Direct interaction between NHERF1 and Frizzled regulates beta-catenin signaling. Oncogene 30:32-42. 66. Liu, X., Brutlag, D.L., and Liu, J.S. 2001. BioProspector: discovering conserved DNA motifs in upstream regulatory regions of co-expressed genes. Pac Symp Biocomput:127-138. 67. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. 1995. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A 92:3046-3050. 68. Clevers, H., and van de Wetering, M. 1997. TCF/LEF factor earn their wings. Trends Genet 13:485-489. 69. Roose, J., Huls, G., van Beest, M., Moerer, P., van der Horn, K., Goldschmeding, R., Logtenberg, T., and Clevers, H. 1999. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285:1923-1926. 70. Baldus, S.E., Monig, S.P., Huxel, S., Landsberg, S., Hanisch, F.G., Engelmann, K., Schneider, P.M., Thiele, J., Holscher, A.H., and Dienes, H.P. 2004. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal 74 carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 10:2790-2796. 71. Schroeder, J.A., Adriance, M.C., Thompson, M.C., Camenisch, T.D., and Gendler, S.J. 2003. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene 22:1324-1332. 72. Bendardaf, R., Lamlum, H., and Pyrhonen, S. 2004. Prognostic and predictive molecular markers in colorectal carcinoma. Anticancer Res 24:2519-2530. 73. Mayer, K., Hieronymus, T., Castrop, J., Clevers, H., and Ballhausen, W.G. 1997. Ectopic activation of lymphoid high mobility group-box transcription factor TCF-1 and overexpression in colorectal cancer cells. Int J Cancer 72:625-630. 74. Liebig, B., Brabletz, T., Staege, M.S., Wulfanger, J., Riemann, D., Burdach, S., and Ballhausen, W.G. 2005. Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin. Cancer Lett 223:159-167. 75. Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L.A., Knuechel, R., and Kirchner, T. 2001. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 98:10356-10361. 76. Hayashi, Y., Molina, J.R., Hamilton, S.R., and Georgescu, M.M. 2010. NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia (New York) 12:1013-1022. 77. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P., et al. 2003. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Research 63:1138-1143. 78. Mazumdar, J., O'Brien, W.T., Johnson, R.S., LaManna, J.C., Chavez, J.C., Klein, P.S., and Simon, M.C. 2010. O2 regulates stem cells through Wnt/beta-catenin signalling. Nature Cell Biology 12:1007-1013. 79. Saotome, I., Curto, M., and McClatchey, A.I. 2004. Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 6:855-864. 80. Perego, C., Vanoni, C., Massari, S., Longhi, R., and Pietrini, G. 2000. Mammalian LIN-7 PDZ proteins associate with beta-catenin at the cell-cell junctions of epithelia and neurons. EMBO J 19:3978-3989. 81. Dobrosotskaya, I.Y., and James, G.L. 2000. MAGI-1 interacts with beta-catenin and is associated with cell-cell adhesion structures. Biochem 75 Biophys Res Commun 270:903-909. 82. Kanamori, M., Sandy, P., Marzinotto, S., Benetti, R., Kai, C., Hayashizaki, Y., Schneider, C., and Suzuki, H. 2003. The PDZ protein tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells. J Biol Chem 278:38758-38764. 83. Alewine, C., Olsen, O., Wade, J.B., and Welling, P.A. 2006. TIP-1 has PDZ scaffold antagonist activity. Mol Biol Cell 17:4200-4211. 84. Manoukian, A.S., Yoffe, K.B., Wilder, E.L., and Perrimon, N. 1995. The porcupine gene is required for wingless autoregulation in Drosophila. Development 121:4037-4044. 85. Kadowaki, T., Wilder, E., Klingensmith, J., Zachary, K., and Perrimon, N. 1996. The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. Genes Dev 10:3116-3128. 86. Logan, C.Y., and Nusse, R. 2004. The Wnt Signaling Pathway in Development and Disease. Annual Review of Cell and Developmental Biology 20:781-810. 87. Yochum, G.S., McWeeney, S., Rajaraman, V., Cleland, R., Peters, S., and Goodman, R.H. 2007. Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proceedings of the National Academy of Sciences 104:3324-3329. 88. Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Lin, J.D., Wang, C.Y., Chinnaiyan, A.M., Lai, Z.C., et al. 2008. TEAD mediates YAP-dependent gene induction and growth control. Genes & Development 22:1962-1971. 89. Chan, S.W., Lim, C.J., Loo, L.S., Chong, Y.F., Huang, C., and Hong, W. 2009. TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation. Journal of Biological Chemistry 284:14347-14358. 90. Zhang, H., Liu, C.Y., Zha, Z.Y., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Lei, Q.Y., and Guan, K.L. 2009. TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition. Journal of Biological Chemistry 284:13355-13362. 91. Varelas, X., Miller, B.W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F.A., Sakuma, R., Pawson, T., Hunziker, W., McNeill, H., et al. 2010. The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 18:579-591. 92. Hergovich, A., and Hemmings, B.A. 2010. TAZ-mediated crosstalk between Wnt and Hippo signaling. Dev Cell 18:508-509. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66204 | - |
| dc.description.abstract | β-連鎖蛋白(β-catenin)在Wnt 訊息傳遞路徑中扮演極重要的角色，Wnt 訊息傳遞路徑調控生物發育的許多階段，例如生物體的形成，細胞型態發生(morphogenesis)過程中的移動，以及細胞增殖。在細胞核中，β-連鎖蛋白與T cell factors (TCFs) 轉錄因子結合並負責調控Wnt 誘導基因的表現。磷酸化蛋白50 能和β-catenin 結合，過度表現磷酸化蛋白50 促進β-連鎖蛋白轉錄活性，然而其作用機制仍未知。我們的研究發現磷酸化蛋白50 會進入細胞核，並且進核行為是受到細胞密度調控。經由ChIP-on-chip 的分析，磷酸化蛋白50 主要結合於具有TCF/LEF 共同序列的啟動子區域。藉著資料庫搜尋，我們發現TCF 轉錄因子isoform TCF-1B 的蛋白質序列符合PDZ 結合motif 的特徵。我們進一步證明磷酸化蛋白50 藉由PDZIdomain 和TCF-1 有交互作用。經由和磷酸化蛋白50 結合，不僅可以加強β-連鎖蛋白和TCF-1 複合物的穩定性，並且能回復β-連鎖蛋白和缺乏β-連鎖蛋白結合區域的TCF 轉錄因子，稱為顯性負向TCF 轉錄因子的結合，進而使顯性負向TCF轉錄因子由抑制轉變成促進生長的角色。同時我們證明磷酸化蛋白50 作用於Wnt 誘導基因啟動子上，並且參與β-連鎖蛋白的轉錄功能。利用siRNA 干擾技術抑制大腸癌細胞中磷酸化蛋白50 蛋白表現，可以減少細胞增殖，細胞的非貼附性生長及裸鼠移植腫瘤的生長。此外，免疫組織染色研究亦發現腫瘤侵入的前緣會異常表現核內磷酸化蛋白50，且此現象與大腸直腸癌病人的預後不佳有顯著相關性。 | zh_TW |
| dc.description.abstract | β-Catenin plays a pivotal role in Wnt signaling pathway which controls a variety of cellular processes during development, such as body patterning, migration during morphogenesis and cell proliferation. T-cell factor (TCF) family transcriptional factors cooperate with β-catenin in the nucleus to regulate the expression of Wnt-responsive genes. EBP50 is a β-catenin-associated protein and overexpression of EBP50 has been known to enhance β-catenin transcriptional activity. However, the underlying mechanism has remained elusive. According to our data, EBP50 displayed a nuclear translocation modulated by cell density. Through ChIP-on-chip assay, we disclosed that nuclear EBP50 predominantly associates with the promoter regions containing TCF/LEF consensus binding sequence. By database search, we found TCF-1B has a PDZ binding motif in its C-terminal end. Thus, we further revealed a novel interaction between nuclear EBP50 and TCF-1 through PDZ1 domain. In spite of stabilizing the interaction between β-catenin and full-length TCF-1, binding of nuclear EBP50 also restores the dnTCF-1/β-catenin binding and converts the dominantly negative dnTCF-1 which lacks a β-catenin binding domain into a tumor facilitator. Also, we demonstrated that nuclear EBP50 was recruited to the promoter regions of β-catenin target genes and participated in β-catenin mediated transcriptional activity. EBP50 knockdown in colonic cancer cells led to reduced cell proliferation, anchorage independent growth, and tumorigenesis in nude mice. Moreover, the immunohistochemistry study identified abnormal EBP50 localization in the nucleus at the tumor invasive fronts the colorectal carcinoma specimens that manifested a poor
clinical outcome. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-17T00:25:33Z (GMT). No. of bitstreams: 1 ntu-101-F93448010-1.pdf: 10370453 bytes, checksum: 803630fe87640065e73c8a2989cc1df9 (MD5) Previous issue date: 2012 | en |
| dc.description.tableofcontents | CONTENTS 1
ABSTRACT 5 中文摘要 6 ABBREVIATIONS 7 INTRODUCTION 8 Brief overview of the Wnt signaling pathway 8 β-Catenin, a key mediator of canonical Wnt pathway 9 The TCF protein family 11 A dual role of EBP50 in cell proliferation and cancer 14 METHODS AND MATERIALS 18 Plasmids 18 Antibodies 18 Cell culture and transfection 18 Viral infection 19 Subcellular fractionation 19 Immunoprecipitation 20 Immunofluorescence 20 In vitro binding assay 21 Reporter assay 21 Tumor xenograft growth assay 21 Colony formation assay 22 Chromatin Immunoprecipitation (ChIP) and RE-ChIP 22 ChIP-on-chip and data analysis 23 Immunohistochemistry 24 RESULTS 26 Nuclear EBP50 facilitates β-catenin/TCF-mediated signaling 26 EBP50 interacts with TCF-1B through its first PDZ domain 28 EBP50 rescues repression effect of dnTCF-1 32 A β-catenin/EBP50/TCF-1 ternary complex is recruited to the promoter of Wnt target genes 33 EBP50 participates in β-catenin-mediated cell growth 34 EBP50 is expressed in the nuclei of tumors in a subset of CRC patients who manifest a poor clinical outcome 36 DISCUSSION AND PROSPECTIVES 39 FIGURES 44 TABLES 64 REFERENCES 68 | |
| dc.language.iso | en | |
| dc.subject | 磷酸化蛋白50 | zh_TW |
| dc.subject | β-連鎖蛋白 | zh_TW |
| dc.subject | TCF-1轉錄因子 | zh_TW |
| dc.subject | 大腸直腸癌 | zh_TW |
| dc.subject | EBP50 | en |
| dc.subject | colorectal cancer | en |
| dc.subject | TCF-1 | en |
| dc.subject | β-catenin | en |
| dc.title | EBP50參與調控β-catenin/TCF-1訊息傳遞之探討 | zh_TW |
| dc.title | Ezrin-radixin-moesin (ERM) Binding Phosphoprotein 50 (EBP50) Coordinates β-catenin/TCF-1 Signaling | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 100-2 | |
| dc.description.degree | 博士 | |
| dc.contributor.oralexamcommittee | 呂勝春,施修明,葉秀慧,吳君泰 | |
| dc.subject.keyword | 磷酸化蛋白50,β-連鎖蛋白,TCF-1轉錄因子,大腸直腸癌, | zh_TW |
| dc.subject.keyword | EBP50,β-catenin,TCF-1,colorectal cancer, | en |
| dc.relation.page | 75 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2012-03-27 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
| 顯示於系所單位： | 分子醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-101-1.pdf 未授權公開取用 | 10.13 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。